|
Participation in Cancer Clinical Trials Is Particularly Low among Minority Populations and Underserved Communities (English-Language) National Cancer Institute ConsumerFeature
-- How Will You Use This Story? -- :60
READER SCRIPT THE NATIONAL CANCER INSTITUTE, OR N-C-I--THE NATION'S CHIEF GOVERNMENT-AGENCY SUPPORTING CANCER-RESEARCH--WANTS TO ENCOURAGE MEMBERS OF MINORITY-POPULATIONS TO LEARN ABOUT CANCER CLINICAL-TRIALS, AND WHAT PARTICIPATION ENTAILS. CANCER CLINICAL-TRIALS ARE IMPORTANT IN DEVELOPING EFFECTIVE PREVENTION-, DIAGNOSTIC-, AND TREATMENT-APPROACHES TO THIS DISEASE. PARTICIPATION IN CLINICAL-TRIALS IS LOW IN ALL GROUPS--BUT IS EVEN LOWER AMONG MINORITY-POPULATIONS AND UNDERSERVED COMMUNITIES. ONE OF THE REASONS FOR THIS IS A LACK OF CREDIBLE INFORMATION ABOUT THE BENEFITS OF CLINICAL-TRIALS IN SOME MINORITY-COMMUNITIES. THAT'S WHY IT'S IMPORTANT TO MAKE SURE THAT PEOPLE GET THE RIGHT INFORMATION. INFORMATION ABOUT PROGRAMS AIMED AT ADVANCING BOTH CANCER-AWARENESS AND CLINICAL-TRIALS AWARENESS IS AVAILABLE BY CALLING THE N-C-I "CANCER INFORMATION SERVICE", AT 1-800-4-"CANCER"--THAT'S 1-800-422-6237--OR BY VISITING W-W-W-DOT-"CANCER"-DOT-GOV. For this report in Spanish, click here. For more information regarding Consumer Radio Network programming--including a full listing of current ConsumerFeatures--click here. |
|